Traveling to Southern Europe? Leishmania Parasite Risks and What You Need to Know
A potentially deadly parasite known as Leishmania is drawing new attention from health officials and travelers heading to popular Southern European destinations. While often associated with tropical climates, the sandfly-borne parasite is active in countries including Spain, Italy, Greece, Portugal, and France, posing a risk that many tourists may overlook.
The Silent Threat: Sandflies and Leishmaniasis
The parasite is transmitted through the bite of infected female phlebotomine sandflies. Unlike mosquitoes, sandflies are silent fliers and are significantly smaller—about one-third the size of a mosquito—making them difficult to detect. They are most active during twilight hours (dawn and dusk) and at night.
When transmitted to humans, the parasite can cause leishmaniasis, which generally manifests in two primary forms:
Cutaneous Leishmaniasis: The most common form, causing skin sores or ulcers that can leave permanent scars.
Visceral Leishmaniasis: A more severe systemic infection affecting internal organs like the spleen, liver, and bone marrow. Symptoms include fever, substantial weight loss, and swelling of the spleen and liver.
Deep Search: Why Is This Happening Now?
Data indicates that rising temperatures and changing climate patterns are expanding the habitable range for sandflies further north and allowing them to survive longer seasons in Southern Europe. Travelers visiting rural areas, staying in villas with gardens, or camping are at higher risk than those staying in urban hotels. The risk is not limited to humans; pet owners traveling with dogs should be aware that canine leishmaniasis is endemic in the Mediterranean basin and can be fatal to dogs without preventative collars or vaccines.
Objections and Reality Check
While the term “deadly” warrants caution, medical experts emphasize that the risk to the average short-term traveler remains relatively low.
Treatability: Leishmaniasis is treatable. The “deadly” classification primarily applies to visceral* leishmaniasis if it is left undiagnosed and untreated. With early medical intervention, the prognosis is generally good.
Asymptomatic Cases: Many people bitten by infected sandflies do not develop the disease. A healthy immune system is often capable of controlling the parasite without the host ever showing symptoms.
Risk Profile: Severe cases are more common among immunocompromised individuals or young children. For the standard healthy adult tourist, the infection—if it occurs—is more likely to be the cutaneous (skin) form rather than the life-threatening visceral form.
Prevention and Safety
Since there are no vaccines for leishmaniasis available for humans, prevention focuses on avoiding bites:
Repellents: Use insect repellents containing DEET, Picaridin, or oil of lemon eucalyptus.
Clothing: Wear long-sleeved shirts and long pants, especially during evening hours.
Screens: Because sandflies are tiny, standard mosquito nets may not be effective. Finer mesh screens or insecticide-treated nets are recommended if sleeping in exposed areas.
Travelers who develop persistent skin sores or unexplained fevers weeks or even months after returning from Southern Europe should inform their doctor of their recent travel history to ensure appropriate testing.
africamuseum.be
travelvax.com.au
inquirer.com
youtube.com
travelclinic.com
appstate.edu
